Concordia Pharma Marketed Plaquenil – Is It the Same as Sanofi-Aventis Product?

Plaquenil (hydroxychloroquine) is prescribed for arthritis and rheumatic disorders, malaria, and a variety of autoimmune disorders such as systemic lupus erythematosus or SLE. In the USA, Plaquenil is marketed by Concordia Pharmaceuticals Inc.  US Plaquenil container labels approved in 2019 state… Continue Reading…